Home > News > Veeco Instruments (NASDAQ:VECO): Buy on Weakness, Short-Term Profit-Taking Provides an Opportunity for Long-Term Investors - J.P. Morgan
May 3rd, 2010
Veeco Instruments (NASDAQ:VECO): Buy on Weakness, Short-Term Profit-Taking Provides an Opportunity for Long-Term Investors - J.P. Morgan
Abstract:
J.P. Morgan is out defending recent high-flier Veeco Instruments (NASDAQ: VECO) this morning reiterating their Overweight rating and $75 price target.
Firm thinks the recent sell-off of VECO is overblown and continues to recommends the stock as their top pick. Although investors are worried about the MOCVD equipment cycle getting too hot and heavy, JPM remains unconcerned about weakness in LED industry fundamentals. They also believe weakness in the stock will be short-lived as they expect news flow over the next few months to be positive for LED demand and drive upside revisions unit demand for LED backlighting and general lighting applications. They are hosting a conference call on Monday morning at 10:30AM EST with the CEO of Veeco, John Peeler.
Source:
streetinsider.com
Bookmark:
| Related Links |
| Related News Press |
Display technology/LEDs/SS Lighting/OLEDs
News and information
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Tools
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
New 2D multifractal tools delve into Pollock's expressionism January 17th, 2025
Turning up the signal November 8th, 2024
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||